(NBIX) Neurocrine Biosciences - Performance -7.2% in 12m
NBIX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
10.24%
#26 in Peer-Group
Rel. Strength
30.24%
#5354 in Stock-Universe
Total Return 12m
-7.17%
#70 in Peer-Group
Total Return 5y
1.14%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 43.0 |
| P/E Forward | 24.8 |
| High / Low | USD |
|---|---|
| 52 Week High | 153.29 USD |
| 52 Week Low | 87.54 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 79.49 |
| Buy/Sell Signal +-5 | 0.00 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NBIX (-7.2%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: NBIX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NBIX
| Total Return (including Dividends) | NBIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.69% | 3.36% | 5.25% |
| 3 Months | 34.98% | 15.73% | 24.13% |
| 12 Months | -7.17% | -7.02% | 14.15% |
| 5 Years | 1.14% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | NBIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 77.3% | 4.4% | 81% |
| 3 Months | 97.6% | 78.8% | 96.9% |
| 12 Months | -41.3% | -85.8% | 44.9% |
| 5 Years | 60.1% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th63.00 | 0.32% | -1.48% |
| 3 Month | %th67.50 | 16.63% | 8.74% |
| 12 Month | %th65.50 | -0.15% | -18.68% |
| 5 Years | %th83.00 | 33.44% | -52.26% |
FAQs
Does Neurocrine Biosciences (NBIX) outperform the market?
No,
over the last 12 months NBIX made -7.17%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months NBIX made 34.98%, while XBI made 15.73%.
Performance Comparison NBIX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NBIX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.2% | -1.6% | -11.3% | -21% |
| US NASDAQ 100 | QQQ | 1.5% | -1.6% | -12% | -20% |
| German DAX 40 | DAX | 3.4% | 5.1% | -23.5% | -36% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.4% | 0.5% | -14.7% | -27% |
| Hongkong Hang Seng | HSI | 1.6% | -2.4% | -30.8% | -46% |
| India NIFTY 50 | INDA | 3.1% | 0.2% | -11.6% | -6% |
| Brasil Bovespa | EWZ | -1.2% | -5.1% | -36.4% | -17% |
NBIX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.6% | -2.2% | -15.5% | -32% |
| Consumer Discretionary | XLY | 1.7% | 0.5% | -3.7% | -25% |
| Consumer Staples | XLP | 0.9% | 3.1% | -13% | -16% |
| Energy | XLE | 0.9% | -3.4% | -7.2% | -7% |
| Financial | XLF | 0.5% | -1.4% | -16.2% | -37% |
| Health Care | XLV | 1.8% | 1.6% | -4% | -3% |
| Industrial | XLI | 1.2% | -0.5% | -19.2% | -32% |
| Materials | XLB | -1% | -0.6% | -15.8% | -13% |
| Real Estate | XLRE | 1.3% | 2.7% | -11% | -20% |
| Technology | XLK | 0.5% | -5% | -13.7% | -18% |
| Utilities | XLU | 2.3% | 1.9% | -14.6% | -30% |
| Aerospace & Defense | XAR | 3.4% | -3.4% | -29.9% | -56% |
| Biotech | XBI | 0.3% | 0.3% | 1.9% | -0% |
| Homebuilder | XHB | -1.3% | -3.3% | -4.2% | -13% |
| Retail | XRT | -1.3% | -1.3% | -7% | -18% |
NBIX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.3% | -4.75% | -2.93% | 0% |
| Natural Gas | UNG | 10.7% | 13.5% | 5.5% | -5% |
| Gold | GLD | 1% | 4.9% | -32% | -46% |
| Silver | SLV | 0.2% | -3.2% | -28.7% | -25% |
| Copper | CPER | 2.2% | -0.9% | -28.4% | -18% |
NBIX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.1% | 2.6% | -7.9% | -5% |
| iShares High Yield Corp. Bond | HYG | 2.4% | 2.1% | -10.2% | -17% |